Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition
Description
CONCLUSIONS AND RELEVANCE: This cohort study found that in people with SARS-CoV-2 infection who had at least 1 risk factor for progression to severe disease, treatment with nirmatrelvir within 5 days of a positive SARS-CoV-2 test result was
